Below are the most recent publications written about "Ischemia" by people in Profiles.
-
Casey RT, Like BJ. Digital Ischemia Secondary to Ulnar Artery Puncture Successfully Treated by Brachial Plexus Block: A Case Report. A A Pract. 2025 Jan 01; 19(1):e01907.
-
Siracuse JJ, Farber A, Menard MT, Rosenfield K, Conte MS, Schanzer A, Doros G, Motaganahalli R, Laskowski IJ, Barshes NR, Genovese EA, Strong MB, Mills JL. Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial. J Vasc Surg. 2025 Mar; 81(3):720-729.e1.
-
Farber A, Menard MT, Conte MS, Rosenfield K, Schermerhorn M, Schanzer A, Powell RJ, Chaar CIO, Hicks CW, Doros G, Strong MB, Leers SA, Motaganahalli R, Stangenberg L, Siracuse JJ. Prosthetic conduits have worse outcomes compared with great saphenous vein conduits in femoropopliteal and infrapopliteal bypass in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025 Feb; 81(2):408-416.e2.
-
Venermo MA, Farber A, Schanzer A, Menard MT, Rosenfield K, Dosluoglu H, Goodney PP, Abou-Zamzam AM, Motaganahalli R, Doros G, Creager MA. Editor's Choice - Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial. Eur J Vasc Endovasc Surg. 2024 Nov; 68(5):590-597.
-
Finn MJ, Sharma A, Guenena M, Jiang Y, Savant SV, Ramsey DJ. Bilateral sequential ischemic retinopathy and optic neuropathy in IgG1 heavy chain deposition disease. Eur J Ophthalmol. 2024 Sep; 34(5):NP65-NP71.
-
Creeden T, Jones DW. "Evolution of Drug-Coated Devices for the Treatment of Chronic Limb Threatening Ischemia". Ann Vasc Surg. 2024 Oct; 107:76-83.
-
Goldsweig AM, Deng Y, Yao X, Desai NR, Cohen DJ, Aronow HD, Mess? SR, Ross JS, Lansky AJ, Savitz ST. Approval, Evidence, and "Off-Label" Device Utilization: The Patent Foramen Ovale Closure Story. Circ Cardiovasc Qual Outcomes. 2024 01; 17(1):e010200.
-
Farber A, Siracuse JJ, Giles K, Jones DW, Laskowski IA, Powell RJ, Rosenfield K, Strong MB, White CJ, Doros G, Menard MT. Investigator attitudes on equipoise and practice patterns in the BEST-CLI trial. J Vasc Surg. 2024 Apr; 79(4):865-874.
-
Menard MT, Jaff MR, Farber A, Rosenfield K, Conte MS, White CJ, Beckman JA, Choudhry NK, Clavijo LC, Huber TS, Tuttle KR, Hamza TH, Schanzer A, Laskowski IA, Cziraky MJ, Drooz A, van Over M, Strong MB, Weinberg I. Baseline modern medical management in the BEST-CLI trial. J Vasc Surg. 2023 09; 78(3):711-718.e5.
-
Qu W, Ralto KM, Qin T, Cheng Y, Zong W, Luo X, Perez-Pinzon M, Parikh SM, Ayata C. NAD+ precursor nutritional supplements sensitize the brain to future ischemic events. J Cereb Blood Flow Metab. 2023 11; 43(2_suppl):37-48.